BRAIN and DECHEMA cooperate in the biotechnological production of perillic acid

07-Mar-2011 - Germany

BRAIN AG and the DECHEMA Society for Chemical Engineering and Biotechnology in Frankfurt have announced a collaboration in the biotechnological production of perillic acid.

This patented natural monoterpene is owned by BRAIN and will be used in a wide range of applications as a bioactive compound in cosmetic products.

The cooperation is aimed at advancing further development of an integrated bio-process for efficient microbial (+)-perillic acid synthesis from the cheap precursor (+) limonene, developed by PD Dr. Jens Schrader and his team at DECHEMA. The compound (+) limonene is extracted in large quantities from orange peel.

By combining the competencies in strain and process optimisation as well as Scale-Up at the Karl-Winnacker-Institute of the DECHEMA, with the microbiological and molecular biological methods of BRAIN, this project is aimed at developing an integrated bio-process for effective technical production.

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances